תוצאות חיפוש - Tamara Krekel
- Showing 1 - 4 results of 4
-
1
-
2
P-1499. Patient Characteristics and Clinical Outcomes Associated with Meropenem/Vaborbactam Treatment in Carbapenem-Resistant <i>Enterobacterales</i> Pneumonia מאת Kaylee E Caniff, Charles S. Judd, Taryn A Eubank, Kevin W. Garey, Tamara Krekel, Wesley D. Kufel, Justin Andrade, John Cerenzio, Michael P. Veve, Michael J. Rybak
יצא לאור 2025Artigo -
3
P-1500. Evaluation of Imipenem-cilastatin-relebactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i> מאת Kaylee E Caniff, Xhilda Xhemali, Nikki Tran, Taryn A Eubank, Kevin W. Garey, Yi Guo, Mei H. Chang, Katie E. Barber, Mark Biagi, Travis J Carlson, Jeremy J Frens, Tamara Krekel, Veena Venugopalan, Wesley D. Kufel, Amy Carr, Jillian E Hayes, James M. Sanders, Elisabeth Chandler, Rosanna Li, Julie Ann Justo, Kayla Antosz, Russell J Benefield, William J Moore, Jennifer Ross, Athena L V Hobbs, Nicholas J. Mercuro, Brian R. Raux, Kristen Zeitler, Michael J. Rybak
יצא לאור 2025Artigo -
4
Real-World Applications of Imipenem/Cilastatin/Relebactam: Insights from a Multicenter Observational Cohort Study מאת Kaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, Nikki Tran, Taryn A Eubank, Kevin W. Garey, Yi Guo, Mei H. Chang, Katie E. Barber, Tamara Krekel, Mark Biagi, Wesley D. Kufel, Amy Carr, Jillian E Hayes, Travis J Carlson, Jeremy J Frens, Veena Venugopalan, Kristen Lucas, Ashlan J. Kunz Coyne, James M. Sanders, Elisabeth Chandler, Rosanna Li, Kayla Antosz, Julie Ann Justo, Russell J Benefield, William J Moore, Jennifer Ross, Jenna C. Adams, Fritzie S Albarillo, Sylvia S. Stefanos, Athena L V Hobbs, Nicholas J. Mercuro, Brian R. Raux, Kristen Zeitler, Michael J. Rybak
יצא לאור 2025Artigo
כלי חיפוש:
נושאים קשורים
Biology
Medicine
Microbiology
Bacteria
Genetics
Antibiotic resistance
Antibiotics
Intensive care medicine
Internal medicine
Antimicrobial stewardship
Bacterial pneumonia
Carbapenem
Cilastatin
Discontinuation
Doripenem
Gram
Imipenem
Imipenem/cilastatin
Intensive care unit
Linezolid
Meropenem
Observational study
Odds ratio
Pathogenic organism
Pneumonia
Pseudomonas aeruginosa
Staphylococcus aureus
Vancomycin